Advertisement

Confirmation of HCV Antibodies by the Line Immunoassay INNO-LIA HCV Ab III

  • Geert Maertens
  • Filip Dekeyser
  • Anja Van Geel
  • Erwin Sablon
  • Fons Bosman
  • Maan Zrein
  • Dirk Pollet
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 19)

Abstract

HCVs constitute a genus within the Flaviviridae, with closest homology to the hepatitis G and GB viruses, and Pestiviruses. The positive-stranded RNA genome encodes at least nine proteins. Core, El, and E2 constitute the structural proteins; NS2, NS3, NS4A, NS4B, NS5A, and NS5B are nonstructural (NS) proteins. HCV isolates display high levels of sequence heterogeneity allowing classification into at least 11 types and 90 subtypes (1). HCV infection of the human liver is often clinically benign, with mild icterus in the acute phase, the disease may even go unnoticed in some cases of acute resolving hepatitis C. In the majority (>70%) of cases, however, HCV infection leads to chronic persistent or active infection, often with complications of liver cirrhosis and auto-immune disorders. Hepatocellular carcinoma may occur after about 20–35 yr (2); sometimes even without the intermediate phase of cirrhosis. No prophylaxis is available today and treatment with interferon-alpha (IFN-α) only leads to long-term resolution in about 4–36% of treated cases, depending on the HCV genotype (1).

Keywords

NS5A Region Antigen Line Test Trough Recombinant Core Protein Adhesive Plate Sealer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Maertens, G and Stuyver, L. (1996) Genotypes and genetic variation of hepatitis C virus, in Molecular Medicine of Hepatitis (Zuckerman, A. and Harrison, T., eds), Molecular Medical Science Series (James, K and Morris A., eds.), John Wiley, Chichester, UK, pp 183–233.Google Scholar
  2. 2.
    Saito, I., Miyamura, T., Ohbayashi, A., Harada, H., Katayama, T., Kikuchi, S., et al. (1990) Proc Natl Acad Set USA 87, 6547–6549CrossRefGoogle Scholar
  3. 3.
    McFarlane, I., Smith, H., Johnson, P., Bray, G., Vergani, D., and Williams, R. (1990) Hepatitis C virus antibodies in chrome active hepatitis: pathogenic factor or false-positive result? Lancet 335, 754–757PubMedCrossRefGoogle Scholar
  4. 4.
    Marin, M., Bresciani, S., Puoti, M., Rodella, A., Gussago, A., Ravaggi, A., et al (1994) Clinical significance of serum HCV RNA as marker of HCV infection J Clin Microbiol 32, 3008–3012PubMedGoogle Scholar
  5. 5.
    Stuyver, L., Fretz, C, Esquivel, C, Boudifa, A., Jaulmes, D., Azar, N., et al. (1996) HCV genotype analysis in apparently healthy anti-HCV positive Parisian blood donors. Transfusion 36(6), 552–558PubMedCrossRefGoogle Scholar
  6. 6.
    Waumans, L., Claeys, H., Verhaert, H., Mertens, W., and Vermylen, C. (1993) Hepatitis C virus confirmation in blood donor screening Vox Sang 64, 145–149PubMedGoogle Scholar
  7. 7.
    Pollet, D., Saman, E., Peeters, D., Warmenbol, H., Heyndricks, L., Wouters, C., et al. (1990) Confirmation and differentiation of antibodies to human immunodeficiency virus 1 and 2 with a strip-based assay including recombinant antigens and synthetic peptides Clin Chem 37, 1700–1707Google Scholar
  8. 8.
    Peeters, D., Dekeyser, F., DeLeys, R., Maertens, G., and Pollet, D. (1993) Confirmation of anti-hepatitis C virus antibodies using the INNO-LIA HCV Ab III including Core, E2/NS1, NS3, NS4, and NS5 epitopes. International Symposium on Viral Hepatitis and Liver Disease, Tokyo, abstract 413.Google Scholar
  9. 9.
    Zaaijer, H., Vrielink, H., van Exel-Oehlers P., Cuypers, H., and Lelie, P. (1994) Confirmation of hepatitis C infection, a comparison of five immunoblot assays. Transfusion 34, 603–607.PubMedCrossRefGoogle Scholar
  10. 10.
    De Beenhouwer, H., Verhaert, H., Claeys, H., and Vermylen, C. (1992) Confirmation of hepatitis C virus positive blood donors by immunoblotting and polymerase chain reaction Vox Sang. 63, 198–203.PubMedCrossRefGoogle Scholar
  11. 11.
    Claeys, H., Volkaerts, A., Verhaert, H., De Beenhouwer, H., and Vermylen C. (1992) Evaluation of anti-HCV capsid indeterminate samples Lancet 340, 249.PubMedCrossRefGoogle Scholar
  12. 12.
    Zaaijer, H., Vallari, D., Cunnigham, M., Lesniewski, R., Reesink, H., van der Poel C, et al. (1994) E2 and NS5. new antigens for detection of hepatitis C virus antibodies. J Med. Virol. 44, 395–397.PubMedCrossRefGoogle Scholar
  13. 13.
    Dow, B., Buchanan, I., Munro, H., Follett, E., Prescott, L., Yap, P., et al. (1996) Relevance of RIBA-3 supplementary test to HCV PCR positivity and genotypes for HCV confirmation of blood donors. J Med Virol 49, 132–136.PubMedCrossRefGoogle Scholar
  14. 14.
    Damen, M., Vrielink, H., Lelie, P., Zaaijer, H., and Reesink, H. (1995) Incorrect Diagnosis of hepatitis C with RIBA-3. Vox Sang 69, 358PubMedCrossRefGoogle Scholar
  15. 15.
    Stuyver, L., van Arnhem, W., Wyseur, A., DeLeys, R., and Maertens, G. (1993) Analysis of the putative El envelope and NS4A epitope regions of HCV type 3. Biochem Biophys Res Comm 192, 635–641PubMedCrossRefGoogle Scholar
  16. 16.
    McOmish, F., Chan, S.-W., Dow, B., et al (1993) Detection of 3 types of hepatitis C virus in blood donors-investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities Transfusion 33, 1357–1359CrossRefGoogle Scholar
  17. 17.
    Chan, S.-W., Simmonds, P., McOmish, F., Yap, P.-L., Mitchell, R., Dow, B., et al (1991) Serological responses to infection with three different types of hepatitis C virus. Lancet 338, 1391PubMedCrossRefGoogle Scholar
  18. 18.
    Miller, R, and Purcell, R (1990) Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad. Sci USA 87, 2057–2061.PubMedCrossRefGoogle Scholar
  19. 19.
    Dow, B., Follett, E., Jordan, T., McOmish, F., Davidson, J., Gillon, J., et al (1994) Testing of blood donations for hepatitis C virus. Lancet 343, 477–478PubMedCrossRefGoogle Scholar
  20. 20.
    Vernelen, K., Claeys, H., Verhaert, H., Volkaerts, A., and Vermylen, C. (1994) Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet 343, 853.PubMedCrossRefGoogle Scholar
  21. 21.
    Attia, M., Zekri, A.-R., Goudsmit, J., Boom, R., Khaled, H., Mansour, M., et al. (1996) Diverse patterns of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors. J Clin. Microbiol 34, 2665–2669.PubMedGoogle Scholar
  22. 22.
    Dussaix, E., Charnaux, N., Laurent-Puig, P., Chopineau, S., Laurian, Y., and Buffet, C. (1994) Analysis of sera indeterminate by Ortho RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody J Clin Microbiol 32, 2071–2075.PubMedGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 1998

Authors and Affiliations

  • Geert Maertens
    • 1
  • Filip Dekeyser
    • 1
  • Anja Van Geel
    • 1
  • Erwin Sablon
    • 1
  • Fons Bosman
    • 1
  • Maan Zrein
    • 1
  • Dirk Pollet
    • 1
  1. 1.Hepatitis ProgramInnogeneticsGentBelgium

Personalised recommendations